Explore more publications!
Seychelles Health News
Got News to Share?

Seychelles Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Seychelles Health News.

February 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

Press releases published on March 31, 2026

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License
Mar. 31, 2026

BriaCell and BriaPro Announce Closing of Asset Purchase Transaction for Exclusive Soluble CD80 License

Indeterminate GlobeNewswire
InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference
Mar. 31, 2026

InspireMD to Participate in Upcoming 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference
Mar. 31, 2026

OrthoPediatrics to Participate in the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update
Mar. 31, 2026

Femasys Announces Financial Results for Year Ended December 31, 2025 and Provides Corporate Update

Indeterminate GlobeNewswire
BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights
Mar. 31, 2026

BioAtla Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

Indeterminate GlobeNewswire
NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026
Mar. 31, 2026

NextCure and Simcere’s SIM0505 (CDH6 ADC) Abstract Accepted for ASCO 2026

Indeterminate GlobeNewswire
MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Mar. 31, 2026

MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference
Mar. 31, 2026

BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update
Mar. 31, 2026

Connect Biopharma Reports 2025 Full-Year Financial Results and Provides Business Update

Indeterminate GlobeNewswire
TOMI Environmental Solutions, Inc. Reports Full Year 2025 Financial Results and Outlines Growth Initiatives
Mar. 31, 2026

TOMI Environmental Solutions, Inc. Reports Full Year 2025 Financial Results and Outlines Growth Initiatives

Indeterminate GlobeNewswire
ORIC® Pharmaceuticals Reports Selection of Rinzimetostat RP3D in Combination with Darolutamide for Himalayas-1 Phase 3 Global Study with Dose Optimization Data Supporting Its Potential Best-in-Disease Profile
Mar. 31, 2026

ORIC® Pharmaceuticals Reports Selection of Rinzimetostat RP3D in Combination with Darolutamide for Himalayas-1 Phase 3 Global Study with Dose Optimization Data Supporting Its Potential Best-in-Disease Profile

Indeterminate GlobeNewswire
Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights
Mar. 31, 2026

Fortress Biotech Reports 2025 Financial Results and Recent Corporate Highlights

Indeterminate GlobeNewswire
Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia
Mar. 31, 2026

Minerva Neurosciences Announces First Patient Screened in Global Phase 3 Confirmatory Trial of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia

Indeterminate GlobeNewswire
Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update
Mar. 31, 2026

Tvardi Therapeutics Announces Fourth Quarter and Full-Year 2025 Results and Provides Business Update

Indeterminate GlobeNewswire
Total number of shares and voting rights in Zealand Pharma as of March 31, 2026
Mar. 31, 2026

Total number of shares and voting rights in Zealand Pharma as of March 31, 2026

Indeterminate GlobeNewswire
Arcutis Management to Present at the 25th Annual Needham Virtual Healthcare Conference
Mar. 31, 2026

Arcutis Management to Present at the 25th Annual Needham Virtual Healthcare Conference

Indeterminate GlobeNewswire
Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2025 Financial Results
Mar. 31, 2026

Jushi Holdings Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

Indeterminate GlobeNewswire
LIXTE Biotechnology Files 2025 Annual Report on Form 10K, Provides Operational Highlights of Transformative Year
Mar. 31, 2026

LIXTE Biotechnology Files 2025 Annual Report on Form 10K, Provides Operational Highlights of Transformative Year

Indeterminate GlobeNewswire
Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome
Mar. 31, 2026

Inhibitor Therapeutics Provides Clinical, Formulation and IP Update on Itraconazole Program for Gorlin Syndrome

Indeterminate GlobeNewswire
As graduation and tax season near, families reconsider keeping young adults on their health plans
Mar. 31, 2026

As graduation and tax season near, families reconsider keeping young adults on their health plans

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions